Are you big pharma's new target market?

By 2018, it is estimated that the global pharmaceutical market will be worth more than $1.3 trillion USD. To corner their share of profits, established drug companies have to fight fierce competition from generic products, ...

Drug companies warm up to continuous manufacturing

For decades, most industries, from petrochemicals to paper, have embraced continuous manufacturing processes. In contrast, the ultraconservative pharmaceutical industry has remained committed to batch operations. But recently, ...

Cloned beef traced to Wisconsin cow

Mark Rueth's Holstein cow Paradise had just been crowned supreme champion of the World Dairy Expo in Madison, Wis., in 2000 when a biotechnology company salesman approached him ringside and offered a cut-rate deal to clone ...

The battle against hard-to-treat fungal infections

Systemic fungal infections are much rarer than other illnesses, but they are potentially deadly, with limited options for treatment. In fact, fungi are becoming increasingly resistant to the few drugs that are available, ...

Acquisitions can nix existing partnerships

Business alliances are valuable because they help companies supplement critical skills, enter new markets, and gain competitive advantages.

page 4 from 9